Study yields positive results for breast cancer imaging agent

03/17/2013 | Yahoo

NuView Life Sciences' PET imaging agent for breast cancer, NLS-VPAC1, was able to detect 100% of malignant lesions and sentinel lymph nodes, according to findings presented at an international conference. Because of the agent's rapid uptake in tumors, the company is also investigating its use when labeled with the isotope gallium-68, which can be manufactured at local radiopharmacies. The agent may allow for noninvasive diagnosis of malignancies in the breast and other tissues, a researcher said.

View Full Article in:

Yahoo

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park